In a new job - October 15, 2014
New CEO for Karolinska Development
Bruno Lucidi has been appointed permanent CEO of Karolinska Development. Bruno Lucidi has previously been founding CEO of Idenix and Chairman of Pharmasset. He has also held senior positions within Bristol-Myers Squibb, Johnson & Johnson and at GlaxoSmithKline. Since September 8, 2014, Bruno Lucidi is CEO of the Karolinska Development’s wholly owned subsidiary KDev Oncology as well […]
In a new job - October 7, 2014
Oslo Cancer Cluster Incubator gets new General Manager
Bjørn Klem has been hired as General Manager for Oslo Cancer Cluster Incubator starting from January 1st 2015. Oslo Cancer Cluster Incubator is a private company, 100% owned by Oslo Cancer Cluster SA. “We are very happy to have Bjørn on board as the first General Manager of the Oslo Cancer Cluster Incubator. He is in deed […]
In a new job - September 30, 2014
Karolinska Development CEO leaves post
Karolinska Development has announced that CEO Torbjörn Bjerke leaves the company. Bjerke will be replaced by Klaus Wilgenbus until a new permanent CEO has been appointed. Torbjörn Bjerke leaves his position as CEO on September 30, 2014, and Klaus Wilgenbus steps down from his Board position in Karolinska Development and assumes his new duties with immediate effect. Karolinska Development states […]
In a new job - September 8, 2014
Kemwell gets new CEO
The contract pharmaceutical development and manufacturing company has appointed Mikael Ericson as new CEO. According to a statement from Kemwell Mikael Ericson is highly experienced in production, logistics and lean management and has held various international management positions in large corporations in both pharmaceutical and automotive industries, such as AstraZeneca, Scania and Plastal Industri. “With his […]
In a new job - August 28, 2014
Moberg Pharma US manager leaves post
Moberg Pharma’s head of US operations, Steve Cagle, will resign by the end of January 2015. Steve Cagle has been part of the management team at Moberg Pharma since November 2012. “I am proud of the achievements during the last two years. We have almost doubled the net sales in the U.S. market and made […]
In a new job - August 12, 2014
Nexstim gets new Chief Financial Officer
Finnish Navigated Brain Stimulation company Nexstim has appointed Mikko Karvinen as its new Chief Financial Officer effective as of 18 August. According to Nexstim, Mikko Karvinen, aged 37, started his career as a financial analyst at OP Bank Group, Vaisala Oyj (in Boston and Boulder, USA) and Automaster Oy and in 2009 he was appointed CFO at SSH Communications Security […]
